Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06YUM
|
|||
| Former ID |
DIB011919
|
|||
| Drug Name |
AZD6423
|
|||
| Indication | Suicidal ideation [ICD-11: MB26.A] | Phase 1 | [1] | |
| Company |
Astrazeneca
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | N-methyl-D-aspartate receptor (NMDAR) | Target Info | Antagonist | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01926366) AZD6423 SAD/MAD Study in Healthy Volunteers. U.S. National Institutes of Health. | |||
| REF 2 | Biology of the NMDA Receptor. Marie L. Blanke and Antonius M.J. VanDongen. 2009. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.